期刊文献+

多发性骨髓瘤患者骨髓中 Treg 细胞与预后相关性研究 被引量:3

Analysis of Treg in bone marrow of patients with multiple myeloma and its correlation with clinical prog-nostic factors
下载PDF
导出
摘要 目的:检测多发性骨髓瘤(Multiple myeloma,MM)患者及正常人外周血和骨髓Treg细胞水平,评价MM患者骨髓微环境的免疫状态,以及免疫状态与疾病水平的相关性。方法采用流式细胞术检测45例MM患者外周血以及骨髓中Treg细胞水平,15例正常人外周血及骨髓中Treg细胞水平。以CD4^+CD25high^+细胞占CD4+细胞的百分比代表Treg细胞水平。结果 MM患者外周血Treg细胞高于正常人外周血,MM患者骨髓中Treg细胞低于正常人骨髓,MM患者骨髓微环境中Treg细胞降低水平与浆细胞比例无关,而与疾病的预后相关,与β2-MG水平及ISS相关。结论 MM骨髓微环境中肿瘤诱导的免疫系统的改变是MM发病的原因之一,MM患者骨髓中Treg细胞降低比例与预后相关,而与肿瘤负担无关。 Objective To evaluate immune function of patients with multiple myeloma ( MM) by detect the changes of the Treg cells in bone marrow of patients with MM .Methods Treg cells in peripheral blood and bone marrow of 45 patients with MM and 15 healthy controls were measured by flow cytometry .Results The per-centage of Treg cells in peripheral blood of MM was higher than that in healthy person ;The percentage of Treg cells in MM bone marrow was lower than that in healthy person ,and the extent was positively correlated with the level of β2-MG and ISS(P〈0.05).Conclusion MM Patients display an abnormal level of CD4^+CD25^+Treg cells,which may be an important mechanism of MM immune deficiency .
出处 《实用肿瘤学杂志》 CAS 2014年第1期54-58,共5页 Practical Oncology Journal
关键词 多发性骨髓瘤 骨髓微环境 TREG细胞 Multiple myeloma Bone marrow microenvironment Treg cells
  • 相关文献

同被引文献18

  • 1Feyler S,Scott GB,Parrish C,et al.Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact dependent and antigen-presenting cell-independent[J].PLoS One,2012,7(5):e35981. 被引量:1
  • 2Shen CJ,Yuan ZH,Liu YX,et al.Increased numbers of T helper 17 cells and the correlation with clinicopathological characteristics in multiple myeloma[J].J Int Med Res,2012,40 (2):556-564. 被引量:1
  • 3Giannopoulos K,Kaminska W,Hus I,et al.The frequency of T regulatory cells modulates the survival of multiple myeloma patients:detailed characterisation of immune status inmultiple myeloma[J].Br J Cancer,2012,106(3):546-552. 被引量:1
  • 4Goodyear OC,Pratt G,McLarnon A,et al.Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undermined significance(MGUS) and multiple myeloma[J].Blood,2008,112 (8):3362-3372. 被引量:1
  • 5Feyler S,von Lilienfeld-Toal M,Jarmin S,et al.CD4(+)CD25 (+)FoxP3(+) regulatory T cells are increased whilst CD3 (+)CD4 (-) CD8 (-) alphabeta TCR (+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden[J].Br J Haematol,2009,144(5):686-695. 被引量:1
  • 6Braga WM,Atanackovic D,Colleoni GW.The role of regulatory T cell and TH17 cells in multiple myeloma[J].Clin Dev Immunol,2012,2012:293479. 被引量:1
  • 7Thomas A, Mailankody S, Korde N, et al. Second malignan- cies after muhiple myeloma: from 1960s to 2010s [ J ]. Blood,2012,119(12) :2731 ' 2737. 被引量:1
  • 8Larson RA, Le Beau MM. Prognosis and therapy when a- cute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy - related myeloid ne- oplasm[ J ]. Mediterr J Hematol Infect Dis, 2011,3 ( 1 ) : e2011032. 被引量:1
  • 9Mailankody S,Pfeiffer RM, Kristinsson SY, et al. Risk of a- cute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS) [ J ].Blood ,2011,118 ( 15 ) :4086 - 4092. 被引量:1
  • 10Tzeng HE, Lin CL, Tsai CH, et al. Time trend of muhiple myeloma and associated sec.ondary primary malignancies in Asian patients :a Taiwan population - based study [ J ]. PIoS One,2013,8(7) :e68041. 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部